ATE311845T1 - Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel - Google Patents

Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel

Info

Publication number
ATE311845T1
ATE311845T1 AT00942559T AT00942559T ATE311845T1 AT E311845 T1 ATE311845 T1 AT E311845T1 AT 00942559 T AT00942559 T AT 00942559T AT 00942559 T AT00942559 T AT 00942559T AT E311845 T1 ATE311845 T1 AT E311845T1
Authority
AT
Austria
Prior art keywords
antioxidants
radical scavengers
pharmaceutical
urocanic acid
acid derivatives
Prior art date
Application number
AT00942559T
Other languages
English (en)
Inventor
Arthur Kammeijer
Joannes Dositheus Bos
Original Assignee
Az Univ Amsterdam
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Az Univ Amsterdam filed Critical Az Univ Amsterdam
Application granted granted Critical
Publication of ATE311845T1 publication Critical patent/ATE311845T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT00942559T 1999-06-25 2000-06-23 Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel ATE311845T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99202066 1999-06-25
PCT/NL2000/000439 WO2001000145A1 (en) 1999-06-25 2000-06-23 Method for scavenging radicals with urocanic acid, derivatives and analogues

Publications (1)

Publication Number Publication Date
ATE311845T1 true ATE311845T1 (de) 2005-12-15

Family

ID=8240366

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00942559T ATE311845T1 (de) 1999-06-25 2000-06-23 Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel

Country Status (12)

Country Link
US (2) US7056938B1 (de)
EP (1) EP1196129B1 (de)
JP (1) JP2003506566A (de)
AT (1) ATE311845T1 (de)
AU (1) AU5716300A (de)
CA (1) CA2376870C (de)
CY (1) CY1104980T1 (de)
DE (1) DE60024628T2 (de)
DK (1) DK1196129T3 (de)
ES (1) ES2253235T3 (de)
SI (1) SI1196129T1 (de)
WO (1) WO2001000145A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ552411A (en) 2004-06-08 2010-04-30 Nsab Af Neurosearch Sweden Ab New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
US7993630B2 (en) * 2007-02-17 2011-08-09 Bioderm Research Protection of skin from UV and peroxide
US20100197752A1 (en) * 2007-06-11 2010-08-05 Arthur Kammeijer Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
US7888127B2 (en) 2008-01-15 2011-02-15 Sequenom, Inc. Methods for reducing adduct formation for mass spectrometry analysis
NO333013B1 (no) 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
TW201124138A (en) * 2009-09-02 2011-07-16 Valletta Health B V Imidazole-4-carboxylic acid for use in treating a disease related to extracellular reactive oxygen species
JP5756615B2 (ja) * 2010-11-02 2015-07-29 花王株式会社 オートインデューサー−２阻害剤、並びに歯周病又は齲蝕病の予防及び／又は治療剤
WO2012122128A2 (en) * 2011-03-04 2012-09-13 Board Of Regents, The University Of Texas System Detection of cancer by volatile organic compounds from breath
US9305756B2 (en) 2013-03-13 2016-04-05 Agena Bioscience, Inc. Preparation enhancements and methods of use for MALDI mass spectrometry

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515789A (en) * 1967-07-17 1970-06-02 Hope City Analgesic-hypnotic therapy with 4-imidazoleacetic acid
JPS5749550B2 (de) * 1972-12-25 1982-10-22
JPH0624978A (ja) * 1992-07-07 1994-02-01 Kuraray Co Ltd 抗アレルギー剤
DE4230076C2 (de) * 1992-09-09 1995-12-14 Beiersdorf Ag cis-Urocaninsäure als Antioxidans
EP0678096B1 (de) 1993-01-08 1997-03-19 HYBRIDON, Inc. Synthese von dimer-blöcken und ihre verwendung bei der zusammensetzung von oligonukleotiden
DE4405585C2 (de) * 1993-03-03 1997-12-11 Beiersdorf Ag Verwendung von trans-Urocaninsäure zur Behandlung oder Prophylaxe der durch oxidative Beanspuchung hervorgerufenen Hautalterung
DE4307983A1 (de) * 1993-03-13 1994-09-15 Beiersdorf Ag Wirkstoffe und kosmetische und dermatologische Zubereitungen
GB9306473D0 (en) 1993-03-29 1993-05-19 Bioglan Lab Ltd Pharmaceutically useful compounds
US6133318A (en) * 1995-11-15 2000-10-17 Hart; Francis J. Oxalic acid or oxalate compositions and methods for bacterial, viral, and other diseases or conditions
US6281244B1 (en) * 1997-06-05 2001-08-28 Novartis Nutrition Ag Therapeutic use for glycine

Also Published As

Publication number Publication date
DE60024628D1 (de) 2006-01-12
SI1196129T1 (sl) 2006-04-30
EP1196129B1 (de) 2005-12-07
EP1196129A1 (de) 2002-04-17
JP2003506566A (ja) 2003-02-18
US7056938B1 (en) 2006-06-06
CA2376870C (en) 2009-11-24
US8026268B2 (en) 2011-09-27
AU5716300A (en) 2001-01-31
CA2376870A1 (en) 2001-01-04
DK1196129T3 (da) 2006-04-03
WO2001000145A1 (en) 2001-01-04
US20060106108A1 (en) 2006-05-18
DE60024628T2 (de) 2006-09-21
ES2253235T3 (es) 2006-06-01
CY1104980T1 (el) 2009-11-04

Similar Documents

Publication Publication Date Title
DE60305724D1 (de) Tetrahydrochinolin-derivate als crth2 antagonisten
GEP20012578B (en) (54) Heteroaryl Succinamides, Pharmaceutical Compositions Containing the Same and Methods for Treatment of the Diseases Caused by Metalloproteinase Activity
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
BR0108677A (pt) Novos compostos
SE9904505D0 (sv) Novel compounds
TR200100918T2 (tr) Aril ve heteroaril sübstitüentli üreler kullanılarak RAF kinazın inhibe edilmesi
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
MY133647A (en) Substituted quinoline-2-carboxamides, their preparation and their use as pharmaceuticals, and intermediates
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
EA200000512A1 (ru) Лекарственные средства, пищевые продукты и напитки с использованием физиологически активных веществ, полученных из морских водорослей
MXPA04004601A (es) Derivados de sulfonamidas, su preparacion y su aplicacion como medicamentos.
YU13396A (sh) N-(3-benzofuranil) urea derivati, postupci za njihovo dobijanje, kompozicije koje ih sadrže i njihova upotreba u lekovima
EA199901031A1 (ru) Производные бензимидазола
CY1110600T1 (el) Αναλογα της βιταμινης d
MXPA04001328A (es) Productos en combinacion de derivados de 1,4-benzotiepina-1,1-dioxido con otros ingredientes activos, y su uso.
MY115211A (en) Novel amino acid derivatives, their preparation and use
ATE231852T1 (de) Bicyclische aromatische verbindungen
DE69705680D1 (de) Heterocyclische diarylverbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen, und ihre verwendung.
ATE200661T1 (de) Bisaromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und verwendungen
MY117323A (en) Method of scavenging free radicals using orange extract
ATE198467T1 (de) Diaromatische propynyl- oder dienylverbindungen
DE60024628D1 (de) Pharmazeutische und kosmetische zubereitungen enthaltend urocaninsäurederivate als antioxidationsmittel oder radikalenabfangermittel
DE69422712D1 (de) Tris-platin-komplexe
IL88971A0 (en) Disubstituted pyridines,their preparation and pharmaceutical compositions containing them
ATE267816T1 (de) Tan-1057 derivate

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1196129

Country of ref document: EP